Emerging roles of ferroptosis in cardiovascular diseases

被引:0
|
作者
Kai Wang
Xin-Zhe Chen
Yun-Hong Wang
Xue-Li Cheng
Yan Zhao
Lu-Yu Zhou
Kun Wang
机构
[1] Qingdao University,Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine
[2] Peking Union Medical College,State Key Laboratory of Cardiovascular Disease, Heart Failure center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
[3] Shandong Provincial Maternal and Child Health Care Hospital affiliated to Qingdao University,Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The mechanism of cardiovascular diseases (CVDs) is complex and threatens human health. Cardiomyocyte death is an important participant in the pathophysiological basis of CVDs. Ferroptosis is a new type of iron-dependent programmed cell death caused by excessive accumulation of iron-dependent lipid peroxides and reactive oxygen species (ROS) and abnormal iron metabolism. Ferroptosis differs from other known cell death pathways, such as apoptosis, necrosis, necroptosis, autophagy and pyroptosis. Several compounds have been shown to induce or inhibit ferroptosis by regulating related key factors or signalling pathways. Recent studies have confirmed that ferroptosis is associated with the development of diverse CVDs and may be a potential therapeutic drug target for CVDs. In this review, we summarize the characteristics and related mechanisms of ferroptosis and focus on its role in CVDs, with the goal of inspiring novel treatment strategies.
引用
收藏
相关论文
共 50 条
  • [21] The emerging roles of machine learning in cardiovascular diseases: a narrative review
    Chen, Liang
    Han, Zhijun
    Wang, Junhong
    Yang, Chengjian
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (10)
  • [22] The emerging roles of long noncoding RNAs in common cardiovascular diseases
    Xiaoying Jiang
    Qilan Ning
    Hypertension Research, 2015, 38 : 375 - 379
  • [23] Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies
    Wu, Changyong
    Bao, Suli
    Sun, Huang
    Chen, Xiaocui
    Yang, Lu
    Li, Ruijie
    Peng, Yunzhu
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (11) : 2827 - 2841
  • [24] Emerging roles of ferroptosis in liver pathophysiology
    Kyu Min Kim
    Sam Seok Cho
    Sung Hwan Ki
    Archives of Pharmacal Research, 2020, 43 : 985 - 996
  • [25] The Emerging Roles of Hydrogen Sulfide in Ferroptosis
    Zhu, Yi-Wen
    Liu, Zi-Tao
    Tang, Ao-Qi
    Liang, Xiao-Yi
    Wang, Yan
    Liu, Ya-Fang
    Jin, Yu-Qing
    Gao, Wei
    Yuan, Hang
    Wang, Da-Yong
    Ji, Xin-Ying
    Wu, Dong-Dong
    ANTIOXIDANTS & REDOX SIGNALING, 2024, 41 (16-18) : 1150 - 1172
  • [26] Emerging roles of ferroptosis in liver pathophysiology
    Kim, Kyu Min
    Cho, Sam Seok
    Ki, Sung Hwan
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (10) : 985 - 996
  • [27] Effects of Ferroptosis on Cardiovascular Diseases
    Xu, Jiayi
    Pi, Jinkui
    Zhang, Yanjing
    Zhou, Jinhan
    Zhang, Shuxia
    Wu, Sisi
    MEDIATORS OF INFLAMMATION, 2023, 2023
  • [28] Emerging Roles of Long Non-Coding RNAs in Cardiovascular Diseases
    Kong, Xiangyue
    Li, Fengjuan
    Wang, Yuan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2025, 29 (05)
  • [29] SIRT3 in cardiovascular diseases: Emerging roles and therapeutic implications
    Lu, Yi
    Wang, Yi-dong
    Wang, Xiao-ya
    Chen, Han
    Cai, Zhe-jun
    Xiang, Mei-xiang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 700 - 705
  • [30] Multifaceted Roles of Ferroptosis in Lung Diseases
    Li, Yi
    Yang, Ying
    Yang, Yongfeng
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9